-
1دورية أكاديمية
المؤلفون: Bouyer, B., Rudnichi, A., Dray‐Spira, R., Zureik, M., Coste, J. *
المصدر: In Journal of Thrombosis and Haemostasis August 2018 16(8):1537-1545
-
2دورية أكاديمية
المؤلفون: Fagot-Campagna, A. †, Weill, A., Paumier, A., Poutignat, N., Fournier, C., Fosse, S., Roudier, C., Romon, I., Chantry, M., Detournay, B., Eschwège, E., Rudnichi, A., Druet, C., Halimi, S.
المصدر: In Médecine des maladies métaboliques March 2010 4(2):212-218
-
3دورية أكاديمية
المؤلفون: Mourad, J-J, Danchin, N, Rudnichi, A, Lopez-Sublet, M, Le Jeune, S, Safar, M EAff3, IDjhh200936_cor6
المصدر: Journal of Human Hypertension. 24(1):51-57
-
4
المؤلفون: Rosemary Dray-Spira, Mahmoud Zureik, Philippe Giral, Jacques Pouchot, Annie Rudnichi, Cécile Billionnet, Joël Coste
المصدر: European Journal of Preventive Cardiology. 26:512-521
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Statin, Databases, Factual, Epidemiology, medicine.drug_class, Disease, 030204 cardiovascular system & hematology, Risk Assessment, Rhabdomyolysis, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Risk Factors, Internal medicine, Primary prevention, Humans, Medicine, 030212 general & internal medicine, Aged, Retrospective Studies, business.industry, Incidence, Middle Aged, medicine.disease, Progression-Free Survival, Primary Prevention, Cardiovascular Diseases, Female, France, Statin therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, business, Cohort study
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa86a150e793633f494c58f2a70c219
https://doi.org/10.1177/2047487318776831 -
5دورية أكاديمية
المؤلفون: Raison, J, Rudnichi, A, Safar, MEAff1, ID1001470_cor3
المصدر: Journal of Human Hypertension. 16(10):705-710
-
6
المؤلفون: Mahmoud Zureik, Joël Coste, Philippe Giral, Alexandre Karras, Rosemary Dray-Spira, Annie Rudnichi, Jacques Pouchot
المساهمون: Université Paris Descartes - Paris 5 (UPD5), Agence nationale de sécurité du médicament et des produits de santé [Saint-Denis] (ANSM), Service de Néphrologie et Hémodialyse [CHU HEGP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Service d'endocrinologie-métabolisme [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP]
المصدر: Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, Wiley, In press, ⟨10.1002/pds.4898⟩مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Statin, Epidemiology, medicine.drug_class, Atorvastatin, Population, primary prevention, Kidney, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, 030226 pharmacology & pharmacy, statins, 03 medical and health sciences, 0302 clinical medicine, Sex Factors, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Risk Factors, Internal medicine, Original Reports, medicine, Humans, Original Report, Pharmacology (medical), Rosuvastatin, Drug Interactions, 030212 general & internal medicine, education, Antihypertensive Agents, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Hazard ratio, Acute kidney injury, Acute Kidney Injury, Middle Aged, medicine.disease, 3. Good health, Cardiovascular Diseases, Cohort, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, France, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, medicine.drug, Cohort study, Follow-Up Studies
-
7دورية أكاديمية
المؤلفون: Safar, Michel E., Vaisse, Bernard, Blacher, Jacques, Rudnichi, Annie, Mourad, Jean-Jacques *
المصدر: In American Journal of Hypertension 2004 17(12):1088-1094
-
8دورية أكاديمية
المؤلفون: Rudnichi, Annie, Safar, Michel E, Lajemi, Malika, Benetos, Athanase
المصدر: In American Journal of Hypertension 2004 17(4):321-327
-
9دورية أكاديمية
المؤلفون: Laurent, Pierre, Albaladejo, Pierre, Blacher, Jacques, Rudnichi, Annie, Smulyan, Harold, Safar, Michel E
المصدر: In American Journal of Hypertension 2003 16(5):363-370
-
10
المؤلفون: Joël Coste, Mahmoud Zureik, A. Rudnichi, R. Dray-Spira, Benjamin Bouyer
المصدر: Journal of thrombosis and haemostasis : JTH.
مصطلحات موضوعية: 030222 orthopedics, medicine.medical_specialty, Proportional hazards model, business.industry, Incidence (epidemiology), Hazard ratio, Hematology, Disease, Scoliosis, medicine.disease, Confidence interval, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Paralysis, Medicine, medicine.symptom, business, 030217 neurology & neurosurgery, Cohort study